Support for the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families

JAMA Psychiatry

Volumn 70, Issue 6, 2013, Pages 582-590

  Timms, Andrew E ^a   Dorschner, Michael O ^a,b   Wechsler, Jeremy ^a   Choi, Kyu Yeong ^c   Kirkwood, Robert ^a   Girirajan, Santhosh ^a,d   Baker, Carl ^a   Eichler, Evan E ^a   Korvatska, Olena ^a   Roche, Katherine W ^c   Horwitz, Marshall S ^a   Tsuang, Debby W ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METABOTROPIC RECEPTOR 5; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA SEQUENCE; EXOME; FAMILY; FRAMESHIFT MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEREDITY; HUMAN; LINKAGE ANALYSIS; MISSENSE MUTATION; PEDIGREE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84878647965     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.1195     Document Type: Article

References (48)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Gejman PV, Sanders AR, Kendler KS. Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum Genet. 2011;12:121-144.
3. Tsuang MT. Genotypes, phenotypes, and the brain: a search for connections in schizophrenia. Br J Psychiatry. 1993;163:299-307. (Pubitemid 23274370)
4. Ng MY, Levinson DF, Faraone SV, et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry. 2009;14(8):774-785.
5. Stefansson H, Ophoff RA, Steinberg S, et al Genetic Risk and Outcome in Psychosis (GROUP). Common variants conferring risk of schizophrenia. Nature. 2009;460(7256):744-747.
6. Ripke S, Sanders AR, Kendler KS, et al Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011;43(10):969-976.
7. Walsh T, McClellan JM, McCarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320(5875):539-543. (Pubitemid 351590668)
8. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet. 2008;40(7):880-885. (Pubitemid 351913650)
9. Girard SL, Gauthier J, Noreau A, et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet. 2011;43(9):860-863.
10. Millar JK, Wilson-Annan JC, Anderson S, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet. 2000;9(9):1415-1423. (Pubitemid 30312490)
11. Bassett AS, Costain G, Fung WL, et al. Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. J Psychiatr Res. 2010;44(15):1005-1009.
12. Consortium IS; International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008;455(7210):237-241.
13. Kirov G, Pocklington AJ, Holmans P, et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 2012;17(2):142-153.
14. Xu B, Roos JL, Dexheimer P, et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet. 2011;43(9):864-868.
15. Bassett AS, Scherer SW, Brzustowicz LM. Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry. 2010;167(8):899-914.
16. Ku CS, Polychronakos C, Tan EK, et al. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry. 2013;18(2):141-153.
17. Cloninger CR, Kaufmann CA, Faraone SV, et al. Genome-wide search for schizophrenia susceptibility loci: the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet. 1998;81(4):275-281. (Pubitemid 28294807)
18. Nurnberger JI Jr, Blehar MC, Kaufmann CA, et al. Diagnostic Interview for Genetic Studies: rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry. 1994;51(11):849-859, discussion 863-864.
19. Maxwell ME. Family Interview for Genetic Studies (FIGS): A Manual for FIGS. Bethesda, MD: NIMH Clinical Neurogenetics Branch; 1992.
20. Girirajan S, Brkanac Z, Coe BP, et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet. 2011;7(11):e1002334.
21. Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP . PLoS Comput Biol. 2010;6(12):e1001025.
22. Lavezzari G, McCallum J, Dewey CM, Roche KW. Subunit-specific regulation of NMDA receptor endocytosis. J Neurosci. 2004;24(28):6383-6391. (Pubitemid 38944229)
23. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011;43(9):838-846.
24. Stefansson H, Rujescu D, Cichon S, et al GROUP. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455(7210):232-236.
25. Pietraszek M, Nagel J, Gravius A, Schäfer D, Danysz W. The role of group Imetabotropic glutamate receptors in schizophrenia. Amino Acids. 2007;32(2):173-178. (Pubitemid 46198740)
26. Ayalew M, Le-Niculescu H, Levey DF, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry. 2012;17(9):887-905.
27. Haas J, Beer AG, Widschwendter P, et al. LRP1b shows restricted expression in human tissues and binds to several extracellular ligands, including fibrinogen and apoE-carrying lipoproteins. Atherosclerosis. 2011;216(2):342-347.
28. Marschang P, Brich J, Weeber EJ, et al. Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1. Mol Cell Biol. 2004;24(9):3782-3793. (Pubitemid 38496157)
29. Girirajan S, Eichler EE. Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet. 2010;19(R2):R176-R187.
30. Spellmann I, Rujescu D, Musil R, et al. Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients. J Psychiatr Res. 2011;45(2):234-241.
31. Gilks WP, Allott EH, Donohoe G, et al International Schizophrenia Consortium. Replicated genetic evidence supports a role for HOMER2 in schizophrenia. Neurosci Lett. 2010;468(3):229-233.
32. Kutuzov MA, Solov'eva OV, Andreeva AV, Bennett N. Protein Ser/Thr phosphatases PPEF interact with calmodulin. Biochem Biophys Res Commun. 2002;293(3):1047-1052. (Pubitemid 34694147)
33. Coyle JT, Balu D, Benneyworth M, Basu A, Roseman A. Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues Clin Neurosci. 2010;12(3):359-382.
34. St Clair D, Blackwood D, Muir W, et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 1990;336(8706):13-16. (Pubitemid 20207869)
35. Devon RS, Anderson S, Teague PW, et al. The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol Psychiatry. 2001;6(3):311-314. (Pubitemid 32275677)
36. Elia J, Glessner JT, Wang K, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet. 2012;44(1):78-84.
37. Ohnuma T, Augood SJ, Arai H, McKenna PJ, Emson PC. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res Mol Brain Res. 1998;56(1-2):207-217. (Pubitemid 28271678)
38. Brody SA, Dulawa SC, Conquet F, Geyer MA. Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors. Mol Psychiatry. 2004;9(1):35-41. (Pubitemid 38175080)
39. Kanuma K, Aoki T, Shimazaki Y. Recent patents on positive allosteric modulators of the metabotropic glutamate 5 receptor as a potential treatment for schizophrenia. Recent Pat CNS Drug Discov. 2010;5(1):23-34.
40. Buchser WJ, Slepak TI, Gutierrez-Arenas O, Bixby JL, Lemmon VP. Kinase/phosphatase overexpression reveals pathways regulating hippocampal neuron morphology. Mol Syst Biol. 2010;6:391.
41. Kolomeets NS, Orlovskaya DD, Rachmanova VI, Uranova NA. Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse. 2005;57(1):47-55. (Pubitemid 40756334)
42. Yang WY, Novembre J, Eskin E, Halperin E. A model-based approach for analysis of spatial structure in genetic data. Nat Genet. 2012;44(6):725-731.
43. Liu CX, Li Y, Obermoeller-McCormick LM, Schwartz AL, Bu G. The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein. J Biol Chem. 2001;276(31):28889-28896.
44. van Zundert B, Yoshii A, Constantine-Paton M. Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends Neurosci. 2004;27(7):428-437.
45. Kiss T, Hoffmann WE, Scott L, et al. Role of thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity. Front Psychiatry. 2011;2:14.
46. Kitano J, Yamazaki Y, Kimura K, Masukado T, Nakajima Y, Nakanishi S. Tamalin is a scaffold protein that interacts with multiple neuronal proteins in distinct modes of protein-protein association. J Biol Chem. 2003;278(17):14762- 14768. (Pubitemid 36799800)
47. Bu G, Cam J, Zerbinatti C. LRP in amyloid-beta production and metabolism. Ann N Y Acad Sci. 2006;1086:35-53.
48. DeMichele-Sweet MA, Sweet RA. Genetics of psychosis in Alzheimer's disease: a review. J Alzheimers Dis. 2010;19(3):761-780.